Cite
Clinical efficacy and changes of serum VEGF-A, VEGF-B, and PLGF after conbercept treating neovascular age-related macular degeneration
MLA
Xiao-Dong Chen, et al. “Clinical Efficacy and Changes of Serum VEGF-A, VEGF-B, and PLGF after Conbercept Treating Neovascular Age-Related Macular Degeneration.” International Journal of Ophthalmology, vol. 16, no. 9, Sept. 2023, pp. 1489–95. EBSCOhost, https://doi.org/10.18240/ijo.2023.09.16.
APA
Xiao-Dong Chen, Chan Li, Guo-Long Ding, Yan Suo, Yu-Sheng Zhu, & Hui-Qin Lu. (2023). Clinical efficacy and changes of serum VEGF-A, VEGF-B, and PLGF after conbercept treating neovascular age-related macular degeneration. International Journal of Ophthalmology, 16(9), 1489–1495. https://doi.org/10.18240/ijo.2023.09.16
Chicago
Xiao-Dong Chen, Chan Li, Guo-Long Ding, Yan Suo, Yu-Sheng Zhu, and Hui-Qin Lu. 2023. “Clinical Efficacy and Changes of Serum VEGF-A, VEGF-B, and PLGF after Conbercept Treating Neovascular Age-Related Macular Degeneration.” International Journal of Ophthalmology 16 (9): 1489–95. doi:10.18240/ijo.2023.09.16.